Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
Titel:
Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
Auteur:
Binder, D. Schweisfurth, H. Grah, C. Schäper, C. Temmesfeld-Wollbrück, B. Siebert, G. Suttorp, N. Beinert, T.